ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans-Reference-Cited by-同舟云学术

ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans

Published:2012-12 Issue:12 Volume:20 Page:2355-2368
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sheehy Susanne H,Duncan Christopher JA,Elias Sean C,Choudhary Prateek,Biswas Sumi,Halstead Fenella D,Collins Katharine A,Edwards Nick J,Douglas Alexander D,Anagnostou Nicholas A,Ewer Katie J,Havelock Tom,Mahungu Tabitha,Bliss Carly M,Miura Kazutoyo,Poulton Ian D,Lillie Patrick J,Antrobus Richard D,Berrie Eleanor,Moyle Sarah,Gantlett Katherine,Colloca Stefano,Cortese Riccardo,Long Carole A,Sinden Robert E,Gilbert Sarah C,Lawrie Alison M,Doherty Tom,Faust Saul N,Nicosia Alfredo,Hill Adrian VS,Draper Simon J

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Global malaria mortality between 1980 and 2010: a systematic analysis;Murray;Lancet,2012

2. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children;Agnandji;N Engl J Med,2011

3. Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy;Duncan;Hum Vaccin Immunother,2012

4. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes;Bouharoun-Tayoun;J Exp Med,1990

5. The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria;Holder;Parasitology,2009

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Full-length MSP1 is a major target of protective immunity after controlled human malaria infection;Life Science Alliance;2024-05-20

2. Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses;Clinical Cancer Research;2024-03-20

3. Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution;Engineering Microbiology;2024-03

4. PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial;npj Vaccines;2024-01-06

5. Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate;Expert Review of Vaccines;2023-12-27